# Leflunomide

NDC: 46708-437
Generic name: Leflunomide
Labeler / Manufacturer: Alembic Pharmaceuticals Limited
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET
Routes: ORAL
Marketing started: 20161201

FDA application: ANDA091369

## Active ingredients

- LEFLUNOMIDE: 20 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"46708-437"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=46708-437
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f6a4107e-b393-45ed-8e5a-70af5bd53826
